ATAI
NasdaqAtaiBeckley Inc.
Basic Materials · Pharmaceutical Preparations
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$308,000
2024
$4.1M
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$4.1M
Net Income$-660.1M
Gross Profit—
Oper Income$-644.1M
EPS (dil)$-2.91
Rev/sh$0.01
FCF/sh$-0.28
Book/sh$0.60
Gross M—
Oper M-15751.1%
Profit M-16144.5%
FCF M-2533.0%
ROE-297.4%
ROA-225.5%
ROIC-450.4%
R&D/Rev22.0%
Rev Y/Y1227.6%
Rev 3Y CAGR—
EPS Y/Y-212.9%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+41.4%
Current Ratio11.74
Quick Ratio—
Debt/Eq0.03
Int Coverage-554.3×
Net Debt$78.9M cash
Total Debt$6.4M
Cash & Eq$85.3M
Total Assets$292.7M
Oper CF$-102.7M
Capex$901,000
Free CF$-103.6M
Buybacks—
Equity$222.0M
Liabilities$70.7M
Shs Outstand0.37B
SectorBasic Materials
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 2 FY| USD | FY2024 | FY2025 |
|---|---|---|
| Revenue | $308,000 | $4.1M |
| Gross Profit | — | — |
| Operating Income | $-102.7M | $-644.1M |
| Net Income | $-150.0M | $-660.1M |
| Diluted EPS | $-0.93 | $-2.91 |
| Operating Cash Flow | $-82.4M | $-102.7M |
| Free Cash Flow | $-82.4M | $-103.6M |
COMMUNITY · $ATAI0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.